MTD
Price
$1283.11
Change
-$2.13 (-0.17%)
Updated
Aug 28 closing price
Capitalization
26.43B
69 days until earnings call
RMD
Price
$275.38
Change
-$6.58 (-2.33%)
Updated
Aug 28 closing price
Capitalization
40.32B
55 days until earnings call
Interact to see
Advertisement

MTD vs RMD

Header iconMTD vs RMD Comparison
Open Charts MTD vs RMDBanner chart's image
Mettler-Toledo International
Price$1283.11
Change-$2.13 (-0.17%)
Volume$182.1K
Capitalization26.43B
ResMed
Price$275.38
Change-$6.58 (-2.33%)
Volume$1.3M
Capitalization40.32B
MTD vs RMD Comparison Chart in %
Loading...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTD vs. RMD commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and RMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (MTD: $1283.11 vs. RMD: $275.38)
Brand notoriety: MTD and RMD are both not notable
MTD represents the Medical Specialties, while RMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MTD: 120% vs. RMD: 129%
Market capitalization -- MTD: $26.43B vs. RMD: $40.32B
MTD [@Medical Specialties] is valued at $26.43B. RMD’s [@Pharmaceuticals: Other] market capitalization is $40.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTD’s FA Score shows that 0 FA rating(s) are green whileRMD’s FA Score has 1 green FA rating(s).

  • MTD’s FA Score: 0 green, 5 red.
  • RMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTD’s TA Score shows that 4 TA indicator(s) are bullish while RMD’s TA Score has 4 bullish TA indicator(s).

  • MTD’s TA Score: 4 bullish, 5 bearish.
  • RMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RMD is a better buy in the short-term than MTD.

Price Growth

MTD (@Medical Specialties) experienced а +0.40% price change this week, while RMD (@Pharmaceuticals: Other) price change was -4.49% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.82%. For the same industry, the average monthly price growth was +6.47%, and the average quarterly price growth was +7.37%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

Reported Earning Dates

MTD is expected to report earnings on Nov 06, 2025.

RMD is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (+0.82% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($40.3B) has a higher market cap than MTD($26.4B). MTD has higher P/E ratio than RMD: MTD (32.53) vs RMD (28.96). RMD YTD gains are higher at: 21.201 vs. MTD (4.857). RMD has higher annual earnings (EBITDA): 1.92B vs. MTD (1.22B). RMD has more cash in the bank: 1.21B vs. MTD (61.8M). RMD has less debt than MTD: RMD (852M) vs MTD (2.18B). RMD has higher revenues than MTD: RMD (5.15B) vs MTD (3.87B).
MTDRMDMTD / RMD
Capitalization26.4B40.3B66%
EBITDA1.22B1.92B63%
Gain YTD4.85721.20123%
P/E Ratio32.5328.96112%
Revenue3.87B5.15B75%
Total Cash61.8M1.21B5%
Total Debt2.18B852M256%
FUNDAMENTALS RATINGS
MTD vs RMD: Fundamental Ratings
MTD
RMD
OUTLOOK RATING
1..100
5857
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
6664
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5521
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (38) in the Medical Specialties industry is somewhat better than the same rating for MTD (99). This means that RMD’s stock grew somewhat faster than MTD’s over the last 12 months.

RMD's Profit vs Risk Rating (64) in the Medical Specialties industry is in the same range as MTD (66). This means that RMD’s stock grew similarly to MTD’s over the last 12 months.

RMD's SMR Rating (100) in the Medical Specialties industry is in the same range as MTD (100). This means that RMD’s stock grew similarly to MTD’s over the last 12 months.

RMD's Price Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for MTD (55). This means that RMD’s stock grew somewhat faster than MTD’s over the last 12 months.

RMD's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as MTD (100). This means that RMD’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTDRMD
RSI
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
52%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
52%
Advances
ODDS (%)
Bullish Trend 17 days ago
61%
Bullish Trend 12 days ago
63%
Declines
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 1 day ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMTM27.950.21
+0.75%
MarketDesk Focused U.S. Momentum ETF
GVUS51.810.03
+0.06%
Goldman Sachs MktBt Russell LgCpValEqETF
NDVG34.95N/A
N/A
Nuveen Dividend Growth ETF
FTRI14.92-0.01
-0.03%
First Trust Indxx Glbl Natrl Res Inc ETF
SCMB25.16-0.01
-0.04%
Schwab Municipal Bond ETF

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-2.33%
SOLV - RMD
46%
Loosely correlated
-0.32%
RVTY - RMD
40%
Loosely correlated
+0.72%
SYK - RMD
39%
Loosely correlated
-0.89%
IDXX - RMD
39%
Loosely correlated
+0.96%
MTD - RMD
38%
Loosely correlated
-0.17%
More